Assaf, C. 2009. “Zanolimumab (HuMax-CD4®), a Fully Human Monoclonal Antibody in Clinical Development for Cutaneous T-Cell Lymphoma”. Hematology Meeting Reports (formerly Haematologica Reports) 2 (5). https://doi.org/10.4081/hmr.v2i5.736.